Arca Biopharma | ABIO - Net Income


Arca Biopharma reported $-29.58M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Amgen USD 1.82B 486M Mar/2026
Arca Biopharma USD -29.58M 694K Dec/2025
Biogen USD 319.5M 368.4M Mar/2026
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 5.55B 1.21B Mar/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Gilead Sciences USD 2.02B 162M Mar/2026
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Grifols EUR 114.37M 34.03M Dec/2025
Laboratory Of America USD 277.8M 113.1M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Otsuka Holdings JPY 98.35B 32.86B Mar/2026
Pfizer USD 2.69B 4.34B Mar/2026
United Therapeutics USD 274.9M 89.4M Mar/2026